A core principle of CTTI’s vision to Transform Trials 2030 is to create a collaborative, patient-centered clinical trials landscape that fully integrates patients and patient organizations into the design and governance of studies. The addition of two new Steering Committee patient/caregiver representatives, Ella Balasa and Megan O’Neil, will play a key role in this bold initiative. 

Balasa and O’Neil, as advocates for the patient/caregiver perspectives, will collaborate with existing Steering Committee members and provide essential information and viewpoints on current patient needs. They will enhance the committee by contributing ideas, helping to conduct and analyze new strategies, disseminating CTTI recommendations, and encouraging the adoption of system changes.   

Both patient representatives selected bring a wealth of experience and unique perspectives that will enrich and inform CTTI’s work to shape practices and increase the quality and efficiency of clinical trials. The contribution of these individual perspectives is essential to the system-wide transformation CTTI is making to the clinical trials landscape. 

Learn more about CTTI’s organizational structure, Steering Committee, and our Transforming Trials 2030 vision.